Cargando…
Time to next treatment and safety assessment in cutaneous‐T‐cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087863/ https://www.ncbi.nlm.nih.gov/pubmed/35822419 http://dx.doi.org/10.1111/bjd.21772 |
| _version_ | 1785022447351758848 |
|---|---|
| author | Roccuzzo, Gabriele Fava, Paolo Avallone, Gianluca Aquino, Carola Boskovic, Sara Macagno, Nicole Ribero, Simone Quaglino, Pietro |
| author_facet | Roccuzzo, Gabriele Fava, Paolo Avallone, Gianluca Aquino, Carola Boskovic, Sara Macagno, Nicole Ribero, Simone Quaglino, Pietro |
| author_sort | Roccuzzo, Gabriele |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10087863 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100878632023-04-12 Time to next treatment and safety assessment in cutaneous‐T‐cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin Roccuzzo, Gabriele Fava, Paolo Avallone, Gianluca Aquino, Carola Boskovic, Sara Macagno, Nicole Ribero, Simone Quaglino, Pietro Br J Dermatol Research Letters John Wiley and Sons Inc. 2022-08-06 2022-12 /pmc/articles/PMC10087863/ /pubmed/35822419 http://dx.doi.org/10.1111/bjd.21772 Text en © 2022 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Research Letters Roccuzzo, Gabriele Fava, Paolo Avallone, Gianluca Aquino, Carola Boskovic, Sara Macagno, Nicole Ribero, Simone Quaglino, Pietro Time to next treatment and safety assessment in cutaneous‐T‐cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin |
| title | Time to next treatment and safety assessment in cutaneous‐T‐cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin |
| title_full | Time to next treatment and safety assessment in cutaneous‐T‐cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin |
| title_fullStr | Time to next treatment and safety assessment in cutaneous‐T‐cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin |
| title_full_unstemmed | Time to next treatment and safety assessment in cutaneous‐T‐cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin |
| title_short | Time to next treatment and safety assessment in cutaneous‐T‐cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin |
| title_sort | time to next treatment and safety assessment in cutaneous‐t‐cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin |
| topic | Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087863/ https://www.ncbi.nlm.nih.gov/pubmed/35822419 http://dx.doi.org/10.1111/bjd.21772 |
| work_keys_str_mv | AT roccuzzogabriele timetonexttreatmentandsafetyassessmentincutaneoustcelllymphomasaretrospectiveanalysisonpatientstreatedwithbexaroteneandacitretin AT favapaolo timetonexttreatmentandsafetyassessmentincutaneoustcelllymphomasaretrospectiveanalysisonpatientstreatedwithbexaroteneandacitretin AT avallonegianluca timetonexttreatmentandsafetyassessmentincutaneoustcelllymphomasaretrospectiveanalysisonpatientstreatedwithbexaroteneandacitretin AT aquinocarola timetonexttreatmentandsafetyassessmentincutaneoustcelllymphomasaretrospectiveanalysisonpatientstreatedwithbexaroteneandacitretin AT boskovicsara timetonexttreatmentandsafetyassessmentincutaneoustcelllymphomasaretrospectiveanalysisonpatientstreatedwithbexaroteneandacitretin AT macagnonicole timetonexttreatmentandsafetyassessmentincutaneoustcelllymphomasaretrospectiveanalysisonpatientstreatedwithbexaroteneandacitretin AT riberosimone timetonexttreatmentandsafetyassessmentincutaneoustcelllymphomasaretrospectiveanalysisonpatientstreatedwithbexaroteneandacitretin AT quaglinopietro timetonexttreatmentandsafetyassessmentincutaneoustcelllymphomasaretrospectiveanalysisonpatientstreatedwithbexaroteneandacitretin |